Jones Trading analyst Justin Walsh reiterated a Hold rating on BioLineRx (NASDAQ: BLRX).The analyst comments "APHEXDA will provide a steady ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE